Medicines A-to-Z

Indometacin (Indocid PDA)

Indometacin capsules

For gout and resistant case

Indometacin M/R capsules

For gout and resistant case

Indometacin suspension (100ml)

For gout and resistant case

Infanrix-IPV

Supported with PGD

Infliximab

TA329 - Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy

Infliximab injection (Remicade®, Inflectra®, Remsima®)

TA199 - Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis
TA195 - Drugs for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor
TA143 - Adalimumab , etanercept and infliximab for ankylosing spondylitis
TA130 - Adalimumab , etanercept and infliximab for the treatment of rheumatoid arthritis
TA375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed
TA715 - Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed

Infliximab#13.5

TA134 - Infliximab for the treatment of adults with psoriasis

Influenza vaccine (Fluenz®)

As per Green book, Health Service Circular, National Flu campaign/service. For intranasal use in children aged 2 years to under 18 years in lin eiwht national flu vaccination programme, Supported with PGD.

Influenza vaccine (Intanza®)

For intradermal use only, Supported with PGD.

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Medicines A–Z

I

Drug name	NICE TAs	Comments
Indometacin (Indocid PDA)
Indometacin capsules		For gout and resistant case
Indometacin M/R capsules		For gout and resistant case
Indometacin suspension (100ml)		For gout and resistant case
Infanrix-IPV		Supported with PGD
Infliximab	TA329 - Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy
Infliximab injection (Remicade®, Inflectra®, Remsima®)	TA199 - Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis TA195 - Drugs for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor TA143 - Adalimumab , etanercept and infliximab for ankylosing spondylitis TA130 - Adalimumab , etanercept and infliximab for the treatment of rheumatoid arthritis TA375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed TA715 - Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed
Infliximab#13.5	TA134 - Infliximab for the treatment of adults with psoriasis
Influenza vaccine (Fluenz®)		As per Green book, Health Service Circular, National Flu campaign/service. For intranasal use in children aged 2 years to under 18 years in lin eiwht national flu vaccination programme, Supported with PGD.
Influenza vaccine (Intanza®)		For intradermal use only, Supported with PGD.